DxGen is global Point-Of-Care(POC) diagnostics company. Our goal is to help make clinical decisions in the care and treatment of patients at the time and place. We are committed to applying leading-edge technology for high-quality products. We endeavor to be a global leader and deliver technical innovation continuously.
DxGen devoted to developing multi-marker for people with diabetes and tuberculosis. We provide total solution and offers tools and services to help developing POC products from concept through commercialization. Healthcare professionals will have reliable test results in minutes with the lab quality precision and accuracy while operating cost effectively.
Founders and leadership of the company are an experienced team composed of industry leaders with successful track records. A powerful combined team with strong R&D capabilities and experience is what truly drives innovation. We are building a global investor, strategic partner and customer base and plan to manufacture components in multiple locations worldwide.
Board of Directors
Dr. Jinwoo Lee is famous entrepreneur and has set out to pioneer In-Vitro Diagnostics (IVD) fields approach to global market by inventing Blood Glucose Monitoring System (BGMS), HbA1c, Hemoglobin meter and Point-of-care (POC) diagnostics systems.
He leaves his footprints in IVD technology especially in diabetes testing in last 20 years. From 1999, he served as Chief Operating Officer (COO) Allmedicus Co., Ltd. to invent the first Korean BGMS by developing "Thin-Film Sputtered Gold Electrode" technology. From 2003, he founded Philosys Inc. and invented MultiCare as ODM with BSI from Italy. From 2005, he founded HUBIT Inc., where he lightened biosensor business era in Korean industry by spreading his experience and technology. In year 2010, HUBIT Inc. has been acquired by CERAGEM group and became CERAGEM MEDISYS Inc. and has been acquired again in 2015 by Green Cross group and became Green Cross Medis Inc. He has directed development of unique and novel IVD product and clinical evaluation to commercialize in global market successfully. In year 2016, he co-founded new high-tech venture company - DxGen Corp. to become global IVD company providing "Complete Diabetes Testing Solution". He is now focusing setup worldwide sales network while developing Glycated Albumin, Glycated Hemoglobin (HbA1c), 1,5-AG, Tuberculosis (TB) Antigen, and so on. Jinwoo Lee is Ph.D. graduate of KAIST majored in semiconductor device and biosensors.
Prof. Tae Jung Park received his Ph.D. degree at the Department of Chemical & Biomolecular Engineering of KAIST in 2004. He has been a professor at the Chemistry department of Chung-Ang University.
His research interests are novel platform technologies for nanobio-fusion studies on metal surfaces, biosensor chips, and nanocomplex fabrication for electrochemical analysis. Furthermore, he is interested in the investigation of molecular diagnostics using nano materials and the evaluation of biomimetics and drug delivery systems. He has received over 12 research awards, published over 120 papers, and holds over 40 international and 80 Korean patents. As Chief Science Officer(C.S.O) at DxGen, he is involved with development of innovative testing system.
Prof.Sung Tack Chung received his Ph.D. degree at the Department of Electronic Engineering of KAIST. He has been a professor at the Computer Science department of Korea Poly-technic University from 2004.
Prof. Sung Tack Chung received his Ph.D. degree at the Department of Electronic Engineering of KAIST. He has been a professor at the Computer Science department of Korea Polytechnic University from 2004. He served as senior researcher of the MRI Department at Medison Co., Ltd. from 1998 to 2000. From 2000 to 2004, he was head of MRI research center at the same company. He wrote 9 books about electronic engineering and published over 200 papers and holds 50 international and 40 Korean patents. He is currently working as Chief Information Officer (C.I.O) at DxGen and deeply interested in NANO detection technology.
Hyukjun Oh received the B.S., M.S., and Ph.D. degrees from the Korea Advanced Institute of Science and Technology (KAIST), in 1993, 1995, and 1999, respectively.
From 1999 to 2000, he was with the Department of Electrical Engineering at Stanford University, where he performed research on next-generation wireless communication systems based on CDMA and OFDM technologies. From 2001 to 2004, he was with the Qualcomm Inc., USA, where he worked on developments of MSM 6000 series for 3GPP UMTS. Since 2004, he has been with the Department of Electronics and Communications Engineering at Kwangwoon University, where he is currently a professor. His research interests include signal processing algorithms for bio/medial sensors, SoC's as well as modem design for wireless communications.